Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abuse, AETHERA, Affordability, Affordable, AMRI, anemia, answer, area, back, Baxter, biosimilar, bring, budget, confirmatory, constitute, convene, CTCL, depleted, digit, disaster, disrupted, disruption, dividing, dollar, drafted, earliest, education, efficiency, eleven, England, entry, EP, export, Factor, False, fire, Folotyn, fraud, GAAP, gastric, Genmab, imprisonment, includingin, indolent, Istodax, jeopardized, Journal, jurisdiction, knowingly, licensure, lifted, Lonza, Medicaid, Medicare, medicine, narrow, NHL, offsite, ordinary, PDUFA, physically, pill, poison, Prescription, President, pronouncement, radiation, referral, refusing, regularly, relevant, remuneration, respiratory, role, Rule, salvage, SEER, sensory, shutdown, soliciting, Statute, theNew, thereunder, thirty, thrombocytopenia, tract, train, twenty, undergo, Union, unsuccessful, upper, view, widespread, willingly
Removed:
abnormal, absence, accept, accumulation, activating, added, advancement, age, antidilutive, apply, AstraZeneca, automatic, Avastin, bacteria, Bexxar, billion, bind, BioPharma, bleeding, blind, bone, bound, bypassing, Campath, capable, carboplatin, category, Certificate, challenging, CHEF, Clolar, combine, conference, convert, converted, convertible, created, cure, Dacogen, daunorubicin, death, decision, deduction, deficiency, designation, desire, die, diversified, DLBCL, donor, double, EGFR, Eli, employed, employing, ending, engineered, entity, Erbitux, etoposide, evaluable, explore, Felix, filled, Gemzar, generation, genetically, goal, Herceptin, humanizing, hybrid, hypomethylating, ideally, ifosfamide, immature, improved, increasingly, incurable, India, ineligible, inhibit, inhibiting, initiation, Institute, intensive, intermediate, judicial, kill, Lilly, linking, liquidated, malignancy, manage, marrow, MDS, MedImmune, mitoxantrone, morbidity, myelodysplastic, myeloproliferative, Mylotarg, neutralize, neutralizing, nonexclusive, notably, Note, onset, par, payload, PDL, percentage, pool, presence, progression, prolong, red, release, restore, selectivity, sending, signal, slightly, suited, sustainable, tolerate, transforming, transfusion, transplantation, uncontrolled, underway, unmet, Vectibix, VEGF, vialing, white, windfall, Zevalin
Filing tables
Filing exhibits
- 10-K Annual report
- 10.14 Amended and Restated 2000 Employee Stock Purchase Agreement
- 10.33 Compensation Information for Executive Officers and Directors
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Section 302 CEO Certification
- 31.2 Section 302 CFO Certification
- 32.1 Section 906 CEO Certification
- 32.2 Section 906 CFO Certification
Related press release
SGEN similar filings
Filing view
External links